- cafead   Jul 12, 2018 at 10:52: PM
via Bioproduction laboratories at French contract manufacturer Cell for Cure could soon be crafting Novartis' cancer cell therapies for clinical and potential commercial use, pending a technology transfer that's planned for 2019.
article source
article source